StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc.

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3017% below fair value
$101.10−0.37 (-0.36%)

Close on Nov 20, 2026Market cap $19.28BP/E 24.6Yield 0.95%

Zimmer Biomet Sponsored Clinical Trials Started by Year

Sponsored Clinical Trials Started — Zimmer Biomet (ClinicalTrials.gov)

Zimmer Biomet Sponsored Clinical Trials Started: 10 in FY2025, up 11.1% from a year earlier.

Latest, FY2025
10
Period ended Dec 31, 2025
Change on a year earlier
+11.1%
9 in FY2024
History
11 years
Since FY2015
Sources
1
NIH ClinicalTrials.gov Registry — Zimmer Biomet

Where the FY2025 figure comes from

Source: NIH ClinicalTrials.gov Registry — Zimmer Biomet ↗

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up sponsored Clinical Trials Started

Cite this data

StockData. (2026). Zimmer Biomet Sponsored Clinical Trials Started, annual FY2015–FY2025 [Data set]. Compiled from Zimmer Biomet SEC filings and investor materials. https://stockdatahq.com/stocks/zbh/kpis/ext-ctgov-started

See every metric in the Zimmer Biomet KPI table. Data updated Nov 14, 2026.

See a number that looks wrong?